
The FDA approved at-home dexmedetomidine film for acute agitation in adults with schizophrenia, schizoaffective disorder, or bipolar I or II disorder.
A discussion on optimizing the number of patients with diabetes who receive screening for diabetic retinopathy to ensure the best quality outcomes.






